We know from previous research that amongst children with attention deficit hyperactivity disorder (ADHD) receiving Omega-3/6 fatty acids—Equazen®—delivering 558mg EPA, 174mg DHA, and 60mg Gamma Linolenic Acid (GLA) in a respective ratio of 9:3:1 over a 12-month duration meant that they did not require such a high dose of methylphenidate to manage and reduce their ADHD symptoms (0.8 mg/kg/day vs. 1.0 mg/kg/day).1
Now, additional research from Researchers from King’s College London and China Medical University in Taichung, Taiwan2 also shows that omega-3 fish oil supplements improve attention among children and adolescents with ADHD that have low levels of omega-3 in their blood.
This was a randomised controlled trial involving 92 children with ADHD aged 6-18 who were given 1.2g daily of the omega-3 fatty acid EPA (eicosapentaenoic acid) or a placebo for 12 weeks. The researchers found that children with the lowest blood levels of EPA showed improvements in focused attention and vigilance after taking the omega-3 supplements.
1. Barragán E et al. (2017) Efficacy and Safety of Omega-3/6 Fatty Acids, Methylphenidate, and a Combined Treatment in Children With ADHD. J Atten Disord 21(5):433-441.
2. High-Dose Eicosapentaenoic Acid 1 (EPA) Improves Attention and Vigilance in Children and Adolescents with Attention Deficit Hyperactivity Disorder (ADHD) and Low Endogenous EPA Levels’ by Chang et al, Translational Psychiatry, DOI: 10.1038/s41398-019-0633-0